争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 1 条
2026
宾夕法尼亚州就涉嫌胰岛素价格串通起诉胰岛素制造商和药品福利管理机构
提起诉讼
宾夕法尼亚州对 Eli Lilly and Co.、Novo Nordisk Inc.、Sanofi-Aventis US LLC 及数家药品福利管理机构（PBM）提起诉讼，指控它们串通抬高胰岛素价格。诉讼要求进行结构性改革、支付赔偿金及罚款。该诉讼将赛诺菲-安万特美国公司列为被告之一，涉及制造商与 PBM 之间在胰岛素定价方面的涉嫌协同行为。
宾夕法尼亚州起诉 Eli Lilly and Co.、Novo Nordisk Inc.、Sanofi-Aventis US LLC 及数家药品福利管理机构，指控它们串通抬高胰岛素价格。诉讼要求进行结构性改革、支付赔偿金及罚款。
来源摘录
The pharmaceutical companies included in the Pennsylvania case are Eli Lilly and Co., Novo Nordisk Inc., and Sanofi-Aventis US LLC. Several PBMs are included as defendants, including Express Scripts, Caremark, and Optum RX.
The state’s lawsuit seeks to institute “structural changes to ensure the companies lower costs to fair market prices and enable options for patients,” restitution for Pennsylvanians harmed by the scheme, and payments including financial penalties paid by the companies and the costs of the state’s investigation and lawsuit.
Last week, Pennsylvania sued a group of pharmaceutical companies and PBMs for allegedly colluding to raise insulin prices unnecessarily.